Cabaletta Bio announces pricing of public offering of securities; shares decline over 28%
Source: SeekingAlpha
2025-06-11 10:09:23 ET
More on Cabaletta Bio
- Cabaletta Bio: Sector Headwinds And Funding Issues... But Also Some Clear Clinical Direction
- Cabaletta Bio slides on proposed securities offering
- Seeking Alpha’s Quant Rating on Cabaletta Bio
- Historical earnings data for Cabaletta Bio
- Financial information for Cabaletta Bio
Read the full article on Seeking Alpha
For further details see:
Cabaletta Bio announces pricing of public offering of securities; shares decline over 28%
Cabaletta Bio Inc.
NASDAQ: CABA
CABA Trading
-6.27% G/L:
$3.065 Last:
867,569 Volume:
$3.20 Open:
CABA Latest News
February 24, 2026 08:00:00 am
Cabaletta Bio to Participate in the TD Cowen 46th Annual Health Care Conference
February 05, 2026 08:00:00 am
Cabaletta Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
CABA Stock Data
$250,770,856
85,435,369
1.33%
21
N/A
Biotechnology & Life Sciences
Healthcare
US
Philadelphia
